LOGIN
TEAM
CONTACT US
COLLECTIONS
Bladder
Breast
Leukemia
Liver
Sarcoma
HOME
You need to enable JavaScript to run this app page.
Breast
BCM-15029
Model Details
Patient
PDX Model
Histology
Metastasis
Patient Treatment
Patient Information for Model: BCM-15029
Patient Information
Clinical Timeline
Color Keys:
Positive
Negative
N/A
Clinical Information at Collection
Clinical Biomarkers/Mutations at Collection
Pathology Information at Collection
Model Information for Model: BCM-15029
Model Details - Initial Implantation of Patient Tissue
Biomarkers & Mutations
Model Details - Acceptable Conditions for Passaging
Mutations (Cancer Gene Census List)
Show/Hide Columns
The number of models in this collection with mutations in the listed gene;
may include models that are not publicly available for distribution.
The number of models in this collection with mutations at the listed site;
may include models that are not publicly available for distribution.
Total mutations showing: 48
F
P
1
2
3
4
N
E
Rows Per Page
10
15
25
50
Download
Gene
Filter by Gene
Chr
Filter by Chr
Start
End
Ref
Alt
cDNA Change
Codon Change
Protein Change
TVAF
Gene Mutation Freq.
Site Mutation Freq.
Most Severe Effect
All Effects
Mutation Impact
Transcript ID
ClinVar Clinical Significance
COSMIC ID
gnomAD Non-Cancer AF
dbSNP ID
Gene Mutation Freq.
Site Mutation Freq.
Transcript ID
ClinVar Clinical Significance
COSMIC ID
dbSNP ID
AKAP9
chr7
92022864
92022864
A
AAAC
c.4004_4006dup
aaa/aAACaa
p.K1335_L1336insQ
0.579
50
35
In-frame Insertion
In-frame Insertion
MODERATE
ENST00000356239.8
COSV62337888
rs10644111
50
35
ENST00000356239.8
COSV62337888
rs10644111
ARID1B
chr6
157190043
157190043
G
C
c.4064G>C
aGt/aCt
p.S1355T
0.953
37
4
Missense Variant
Missense Variant
MODERATE
ENST00000636930.2
COSV104368469
37
4
ENST00000636930.2
COSV104368469
ATR
chr3
142469495
142469495
A
C
c.6394T>G
Tat/Gat
p.Y2132D
0.531
13
4
Missense Variant
Missense Variant
MODERATE
ENST00000350721.9
Benign/Likely_benign
COSV63384218
0.003051310000
rs28910273
13
4
ENST00000350721.9
Benign/Likely_benign
COSV63384218
rs28910273
BARD1
chr2
214780778
214780799
GTGGTGAAGAACATTCAGGCAA
G
c.1075_1095del
TTGCCTGAATGTTCTTCACCA/-
p.L359_P365del
0.955
34
7
In-frame Deletion
In-frame Deletion
MODERATE
ENST00000260947.9
COSV53608540
rs28997575
34
7
ENST00000260947.9
COSV53608540
rs28997575
BCL9
chr1
147619827
147619827
A
T
c.1672A>T
Agc/Tgc
p.S558C
0.454
11
1
Missense Variant
Missense Variant
MODERATE
ENST00000234739.8
11
1
ENST00000234739.8
BCLAF1
chr6
136276251
136276251
G
A
c.1274C>T
aCt/aTt
p.T425I
0.439
4
4
Missense Variant
Missense Variant
MODERATE
ENST00000531224.6
rs61757627
4
4
ENST00000531224.6
rs61757627
BCLAF1
chr6
136278195
136278195
G
A
c.686C>T
cCt/cTt
p.P229L
0.106
4
4
Missense Variant
Missense Variant
MODERATE
ENST00000531224.6
COSV104666285
0.000080251400
rs753799977
4
4
ENST00000531224.6
COSV104666285
rs753799977
CDH11
chr16
64988331
64988331
C
T
c.825G>A
atG/atA
p.M275I
0.717
6
2
Missense Variant
Missense Variant
MODERATE
ENST00000268603.9
Benign
COSV51754932
0.196252000000
rs1130821
6
2
ENST00000268603.9
Benign
COSV51754932
rs1130821
CIITA
chr16
10909070
10909070
A
G
c.2702A>G
cAg/cGg
p.Q901R
0.956
85
84
Missense Variant
Missense Variant
MODERATE
ENST00000618327.4
Benign
0.983235000000
rs7197779
85
84
ENST00000618327.4
Benign
rs7197779
CLTCL1
chr22
19234688
19234688
C
T
c.988G>A
Gag/Aag
p.E330K
0.963
19
4
Missense Variant
Missense Variant
MODERATE
ENST00000427926.6
Likely_pathogenic
0.000485627000
rs199652160
19
4
ENST00000427926.6
Likely_pathogenic
rs199652160
COL1A1
chr17
50185965
50185965
A
T
c.4061T>A
tTc/tAc
p.F1354Y
0.484
11
1
Missense Variant
Missense Variant
MODERATE
ENST00000225964.10
11
1
ENST00000225964.10
CREB3L2
chr7
137928167
137928170
CTGG
C
c.299_301del
aCCAgt/agt
p.T100del
0.938
49
49
In-frame Deletion
In-frame Deletion
MODERATE
ENST00000330387.11
COSV57791862
rs3217268
49
49
ENST00000330387.11
COSV57791862
rs3217268
ERCC2
chr19
45351661
45351661
T
G
c.2251A>C
Aag/Cag
p.K751Q
0.361
48
46
Missense Variant
Missense Variant
MODERATE
ENST00000391945.10
Benign/Likely_benign
COSV67266431
0.322955000000
rs13181
48
46
ENST00000391945.10
Benign/Likely_benign
COSV67266431
rs13181
FBXW7
chr4
152326139
152326139
A
C
c.1511T>G
gTc/gGc
p.V504G
0.983
5
4
Missense Variant
Missense Variant
MODERATE
ENST00000281708.10
5
4
ENST00000281708.10
FLT4
chr5
180603322
180603322
C
T
c.3962G>A
cGg/cAg
p.R1321Q
0.94
12
4
Missense Variant
Missense Variant
MODERATE
ENST00000261937.11
Benign/Likely_benign
COSV56126176
0.008583970000
rs79620092
12
4
ENST00000261937.11
Benign/Likely_benign
COSV56126176
rs79620092
Total mutations showing: 48
F
P
1
2
3
4
N
E
Rows Per Page
10
15
25
50
Download
CNV
Histology Information for Model: BCM-15029
Patient
PDX
ER
HER2
PR
Metastasis Information for Model: BCM-15029
Patient
PDX
Abdomen
Abdominal cavity
Adrenal Gland
Anterosuperior mediastinum
Ascites
Axillary Lymph Node
Bone
Brain
CTC
Chest
Chest wall
Contralateral Breast
Fallopian tubes
Head
Hilar Node
Hip
Kidney
Leg bone
Leptomeninges
Liver
Lung
Lymph Node
Mediastinum
Metastasis Pleura
Neck
None
Other
Ovary
Pancreas
Paratracheal adenopathy
Pericardium
Peritoneal cavity
Peritoneum
Pleura
Pleural cavity
Pleural effusion
Posterior cervical nodes
Pulmonary
Retrocrural Lymph Node
SVC node
Sacral Spine
Skin
Spine
Spleen
Thymus
Patient Treatment Information for Model: BCM-15029
Event Id
Treatment
Treatment Setting
Age at Start
Age at End
Duration
Clinical Response
Pathologic Response
Reason Stopped
10
Cyclophosphamide,Doxorubicin,Radiation Therapy (RT)
Adjuvant
46.89
47.56
245 days
Not Reported
Not Reported
Treatment Completed
25
Carboplatin, Docetaxel
Neoadjuvant
63.04
63.27
84 days
Partial Response
Partial Response
Side Effects
Timeout
Your session is about to expire. Click 'Stay Connected' to continue the session.
Stay Connected